Avicanna Marks Milestone with Initial Delivery of Proprietary Topical Products to European MarketBusiness PenDecember 2, 2024 December 2, 2024 Avicanna Inc. (TSX: AVCN, OTCQX: AVCNF, FSE: 0NN), a Toronto-based biopharmaceutical company specializing in cannabinoid-based products, has achieved a significant milestone by completing its first...
